tiprankstipranks
JW Pharmaceutical Corporation (KR:001060)
:001060
South Korea Market
001060
JW Pharmaceutical Corporation
RESEARCH TOOLSreports

JW Pharmaceutical Corporation (001060) Financial Statements

― Followers

JW Pharmaceutical Corporation Financial Overview

JW Pharmaceutical Corporation's market cap is currently ₩537.08B. The company's EPS TTM is $2958.45; its P/E ratio is 7.94; JW Pharmaceutical Corporation is scheduled to report earnings on May 15, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 774.80B₩ 719.38B₩ 748.53B₩ 684.35B₩ 606.58B
Gross Profit₩ 359.31B₩ 323.50B₩ 335.67B₩ 287.95B₩ 234.38B
Operating Income₩ 87.88B₩ 82.49B₩ 96.63B₩ 62.96B₩ 31.20B
EBITDA₩ 106.62B₩ 110.17B₩ 89.22B₩ 73.45B₩ 45.13B
Net Income₩ 61.69B₩ 65.04B₩ 37.01B₩ 31.89B₩ -919.18M
Balance Sheet
Cash & Short-Term Investments₩ 60.25B₩ 32.55B₩ 92.84B₩ 149.68B₩ 65.67B
Total Assets₩ 605.27B₩ 604.60B₩ 645.04B₩ 627.97B₩ 633.05B
Total Debt₩ 54.63B₩ 91.73B₩ 170.28B₩ 209.54B₩ 245.14B
Net Debt₩ 15.40B₩ 81.30B₩ 154.37B₩ 175.64B₩ 211.78B
Total Liabilities₩ 235.90B₩ 275.11B₩ 379.60B₩ 402.21B₩ 444.51B
Stockholders' Equity₩ 369.37B₩ 329.49B₩ 265.44B₩ 240.35B₩ 201.19B
Cash Flow
Free Cash Flow₩ 84.62B₩ 51.25B₩ 46.45B₩ 44.41B₩ 5.22B
Operating Cash Flow₩ 96.40B₩ 79.39B₩ 87.16B₩ 56.76B₩ 18.12B
Investing Cash Flow₩ -7.20B₩ 14.08B₩ -63.83B₩ -18.92B₩ -22.87B
Financing Cash Flow₩ -59.78B₩ -100.19B₩ -41.19B₩ -36.91B₩ 27.20B
Currency in KRW

JW Pharmaceutical Corporation Earnings and Revenue History

Income Statement >

JW Pharmaceutical Corporation Debt to Assets

Balance Sheet >

JW Pharmaceutical Corporation Cash Flow

Cash Flow >

JW Pharmaceutical Corporation Forecast EPS vs Actual EPS

Earnings >